Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus brevis and Lactobacillus plantarum for Periodontitis
NCT06253988Phase 3Completed
- Sponsor
- Al-Azhar University
- Start
- Jan 2023
- Primary completion
- Feb 2023
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of lactobacillus brevis + lactobacillus plantarum in periodontitis, sponsored by Al-Azhar University. Started Jan 2023; status: completed.
02
Drugs
lactobacillus brevis + lactobacillus plantarum
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT06253988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06253988.